Editorials |
From the Institute of Cardiovascular Sciences, St. Boniface General Hospital Research, Centre, Departments of Physiology, Pharmacology, & Therapeutics, Faculty of Medicine, University of Manitoba, Winnipeg.
Correspondence to Dr Lorrie A. Kirshenbaum, Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre Rm. 3016, 351 Taché Avenue, Winnipeg, Manitoba, Canada, R2H 2A6. E-mail Lorrie@sbrc.ca
See related article, pages 111118
Key Words: apoptosis signal transduction Akt/PKB hypoxia-reoxygenation
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
Apoptosis is an energy-dependent cell suicide program that requires a change in gene expression. Two predominate pathways have been identified to be important for initiating the apoptotic program: a surface death receptor-mediated "extrinsic" pathway, and a mitochondria-mediated "intrinsic" pathway, both of which result in the activation of cellular proteases known as caspases.4,7 The former is activated by ligands such as TNF-
or Fas binding to cell surface death receptors, the latter activated by internal cues that follow cellular stresses including hypoxia, oxidative stress, toxins, and environmental triggers. An important family of proteins involved in regulating apoptosis is the Bcl-2 family, which includes both cytoprotective (Bcl-2, Bcl-XL) and apoptotic (Bid, Bax, Bad, Noxa, Puma, Bnip3) members. Collectively, these proteins regulate the
Related Article:
Circ. Res. 2006 98: 111-118.
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |